Natixis Haemonetics Corp Transaction History

Natixis

$17.6 Billion
Q3 2024

A detailed history of Natixis transactions in Haemonetics Corp stock. As of the latest transaction made, Natixis holds 1 shares of HAE stock, worth $60. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 1 -0.0%

Holding current value

$60

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$71.24 - $85.35 $71 - $85	1 New	1 $0
Q4 2022 Feb 13, 2023	BUY	$73.85 - $86.14 $1.36 Million - $1.58 Million	18,352 New	18,352 $1.44 Million
Q1 2021 May 14, 2021	SELL	$111.01 - $139.48 $310,272 - $389,846	-2,795 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$88.75 - $119.95 $85,555 - $115,631	-964 Reduced 25.65%	2,795 $332,000
Q3 2020 Nov 12, 2020	SELL	$75.65 - $93.58 $97,512 - $120,624	-1,289 Reduced 25.53%	3,759 $328,000
Q2 2020 Aug 13, 2020	SELL	$84.96 - $118.91 $3,908 - $5,469	-46 Reduced 0.9%	5,048 $452,000
Q1 2020 May 14, 2020	SELL	$74.34 - $121.82 $343,896 - $563,539	-4,626 Reduced 47.59%	5,094 $508,000
Q4 2019 Feb 14, 2020	BUY	$114.37 - $129.46 $173,728 - $196,649	1,519 Added 18.52%	9,720 $1.11 Million
Q3 2019 Nov 13, 2019	BUY	$117.16 - $138.52 $115,988 - $137,134	990 Added 13.73%	8,201 $1.03 Million
Q2 2019 Aug 13, 2019	SELL	$81.74 - $120.34 $205,330 - $302,294	-2,512 Reduced 25.84%	7,211 $868,000
Q1 2019 May 15, 2019	SELL	$83.25 - $102.12 $7,575 - $9,292	-91 Reduced 0.93%	9,723 $833,000
Q4 2018 Feb 14, 2019	BUY	$90.66 - $116.63 $52,038 - $66,945	574 Added 6.21%	9,814 $982,000
Q3 2018 Nov 14, 2018	SELL	$89.96 - $114.58 $485,514 - $618,388	-5,397 Reduced 36.87%	9,240 $1.06 Million
Q2 2018 Aug 14, 2018	SELL	$71.53 - $95.75 $49,999 - $66,929	-699 Reduced 4.56%	14,637 $1.31 Million
Q1 2018 May 15, 2018	BUY	$60.72 - $74.41 $175,237 - $214,747	2,886 Added 23.18%	15,336 $1.12 Million
Q4 2017 Feb 14, 2018	SELL	$44.96 - $58.99 $40,823 - $53,562	-908 Reduced 6.8%	12,450 $723,000
Q3 2017 Nov 14, 2017	BUY	$40.38 - $44.87 $539,396 - $599,373	13,358	13,358 $599,000

Others Institutions Holding HAE

# of Institutions

341

Shares Held

54.6M

Call Options Held

689K

Put Options Held

345K

Black Rock Inc. New York, NY

5.96M
Shares

$361 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

5.17M
Shares

$313 Million
0.01% of portfolio
Capital Research Global Investors Los Angeles, CA

4.44M
Shares

$269 Million
0.08% of portfolio
Wellington Management Group LLP Boston, MA

4.2M
Shares

$255 Million
0.06% of portfolio
Neuberger Berman Group LLC New York, NY

4.03M
Shares

$244 Million
0.26% of portfolio

View Full List

About HAEMONETICS CORP

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $3.11B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

More about HAE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Account